A similar behavior was identified for adipsin levels which were significantly higher in the MS group (1.20 [0.79–1.56]) compared with the obese (0.90 [0.64–1.57]) and the normal weight groups (0.64 [0.38–0.80]). This evidence concerns the gene CFD and myeloid sarcoma.